Lustgarten Researchers

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin

As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]

Research

Clinical Trials Finder

July 30, 2018 ladmin

If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.

Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin

LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin

Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery.

Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

Pancreatic Cancer Meeting Highlights

AACR Highlights: Monday, September 9

Cancer cells divide uncontrollably resulting in a flood of new tumor cells and this uncontrolled metabolic wave requires energy.

But metabolism is altered in pancreatic cancer and scientists are trying to understand the molecular underpinnings of the nutrients of choice for various cell types. These new insights into cancer metabolism kicked off the third and final day of plenary sessions at the AACR special conference on pancreatic cancer, bringing together the best minds in pancreatic cancer research. Also on the docket: new model systems, animals and beyond. Scientists are using genetically engineered mouse models that closely recapitulate human pancreatic cancer as well as organoids, small three-dimensional tumors that are grown right from the cells of patient’s tumors. Organoids in particular are potentially bringing us one step closer to personalized medicine for pancreatic cancer patients.

 

Learn More

Possible drug target for pancreatitis

 Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary pancreatitis have a 40 to 50 percent lifetime risk of developing pancreatic cancer. Dannielle Engle, a former Cold Spring Harbor Laboratory (CSHL) Cancer Center postdoctoral fellow who was recently appointed Assistant Professor at Salk Institute, studies the progression of pancreatitis to pancreatic cancer. She has focused on a potentially powerful biomarker, a chemical structure created by complex sugar molecules called CA19-9, since CA19-9 is elevated in patients with pancreatitis and pancreatic cancer.

Learn More

Tune in with
“Jeopardy! James”

Join “Jeopardy! James” in the Fight

Tune in tonight, Monday, September 9th, as the 36th season of Jeopardy! kicks off. We will be watching and look forward to cheering on the iconic game show host Alex Trebek on as he reprises his role for this upcoming season after his pancreatic cancer diagnosis five months ago and subsequent treatment.

In a recent article, Trebek promised viewers an entertaining season ahead. “We’ve got some exciting things coming up, and I can’t wait to share them with all of you,” said Trebek in the article. “Let me tell you, it’s going to be a good year.”

Even Jeopardy! James, James Holzhauer, who won an impressive 32-straight games on the show, will be tuning in to wish his friend well. Watch the short video he shared ahead of the show’s premiere below.

Trebek’s courageous fight is giving hope to thousands of patients and their families who have been affected by this disease. Join us and Jeopardy! James tonight as Jeopardy! returns.

In honor of Trebek and everyone else impacted by pancreatic cancer, please consider donating $36 for season 36. 100% of your donation goes directly to research leading toward a cure.

Follow the Lead of “Jeopardy! James”

Naperville Walk Team

We all watched in disbelief as Alex Trebek shared in March that he was suffering from Stage IV pancreatic cancer. This news hit Naperville, IL Walk leader Ann Zediker especially hard, as she lost her own father to the disease in 2010, just five months after he was diagnosed. She watched a man who loved life deteriorate during treatment. Now, Ann is fighting for continued research and a cure.

This year, Jeopardy! champion James Holzhauer, who won an impressive 32-straight games, caught her attention. After seeing him on the show, she learned that he was born and raised in Naperville, and she invited him to attend this year’s walk on Saturday, July 14th. While he couldn’t attend, he has added his support to the Naperville Walk in honor of Alex Trebek and all the other survivors. His generous donation of $1,109.14 represents his daughter’s birthday (November 9, 2014).

We encourage you to follow James’ example and donate amounts corresponding to your birthday, in honor or in memory of a loved one, or in support of Alex Trebek.

Your contribution will make a difference in detecting the disease earlier, developing better treatments and eventually finding a cure! And, thanks to separate funding to support administrative expenses, 100% of your donation goes directly to pancreatic cancer research.

Register Donate

 

Related Media:

NBC: ‘Jeopardy!’ champ James Holzhauer makes pancreatic cancer donation in Alex Trebek’s name
CBS: “Jeopardy James” Holzhauer donates to pancreatic cancer research to honor Alex Trebek
Fox News: “Jeopardy!’ champ James Holzhauer donates to pancreatic cancer charity walk in Trebek’s honor
CNN: “Jeopardy!” Champion James Holzhauer donated to a cancer walk in Alex Trekek’s name
ABC Chicago:  “Jeopardy! James” Holzhauer donates $1K to Naperville pancreatic cancer research walk
Chicago Tribune: ‘Jeopardy!’ champ James Holzhauer makes donation in Alex Trebek’s name to Naperville pancreatic cancer walk
Yahoo:  ‘Jeopardy!’ champion James Holzhauer donates to pancreatic cancer walk in Alex Trebek’s name
Survivornet: As Alex Trebek continues his journey with pancreatic cancer “Jeoparty James” contributes part of his fortune to finding its cure

Learn More

Pancreatic Cancer News

View All Articles

A compound may improve pancreatic cancer survival rate, scientists find

19. 9. 19 ladmin

Scientists have discovered a compound could help slow down pancreatic cancer by targeting proteins that promote metastatic cells. Researchers at Johns Hopkins Medicine found that the compound, 4-HAP, reduced tumors in mice and could improve survival for pancreatic cancer patients. According to the National Cancer Institute, 73,554 people in the U.S. have pancreatic cancer and […]

Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients

9. 9. 19 ladmin

a leading medical genetics company, today announced the availability of Detect Hereditary Pancreatic Cancer, a testing program that offers no-charge genetic testing and counseling to patients with pancreatic cancer. Genetic testing is recommended by clinicians for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials. “Genetic information can be particularly valuable for […]

MD Anderson study confirms protein as potential cause of most common type of pancreatic cancer

4. 9. 19 ladmin

Researchers at The University of Texas MD Anderson Cancer Center have confirmed a protein as an oncogene responsible for the most common and lethal form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). The team’s findings, which validated ubiquitin specific protease 21 (UPS21) as a frequently amplified gene and a potential druggable target, appear in the Sept. 5 […]

Key to targeting the spread of pancreatic cancer

12. 8. 19 ladmin

An international team of researchers has revealed how aggressive pancreatic cancer cells change their environment to enable easy passage to other parts of the body (or metastasis) – the main cause of pancreatic cancer related death. The researchers discovered that some pancreatic tumours produce more of a molecule called ‘perlecan’ to remodel the environment around them, which […]

Inherited pancreatic cancer risk mutation identified

12. 8. 19 ladmin

Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers. The discovery of the previously unknown mutation, reported in Nature Genetics by investigators from Dana-Farber/Brigham and Women’s Cancer Center, could lead to routine testing of individuals with a strong family history […]

Pancreatic Cancer: Less Toxic, More Enduring Drug May Improve Therapy

8. 8. 19 ladmin

Unlike many other cancers, most pancreatic tumors are rock hard. “That’s one reason why pancreatic cancer is one of the most lethal types of cancer,” says Kenneth Olive, PhD, associate professor of medicine and pathology & cell biology at Columbia University Vagelos College of Physicians and Surgeons and a pancreatic cancer researcher at the Herbert […]

Scientists develop promising drug for treating ovarian, pancreatic cancers

22. 7. 19 ladmin

Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms. As a result, they frequently go undetected until they’re too late to effectively treat. Cancer scientists at Houston Methodist and The University of Texas MD Anderson Cancer Center have been vigilant about […]

Test shown to improve accuracy in identifying precancerous pancreatic cysts

17. 7. 19 ladmin

Johns Hopkins Kimmel Cancer Center study coauthors Anne Marie Lennon, Simeon Springer, Marco Dal Molin, Christopher Wolfgang and Bert Vogelstein will participate in a press teleconference organized by the American Association for the Advancement of Science at 11 a.m. Tuesday, July 16. To RSVP, send an email to scipak@aaas.org. An audio recording and transcript will be […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top